The Biotechnology Agreement will contain terms for licensing of intellectual property developed by us.
Cymra will have an ongoing breeding program and regularly release new varieties which will be offered on a licensing and royalty program. Cymra’s intention is that the new varieties will have improved desirable characteristics such as disease/pest resistance, increased yield, increased agronomic efficiencies.
Want to keep up to date with the latest Medical Cannabis Information in Australia and from around the world? We will send you informative information from time to time so you can learn about cannabis and if it can help you.